article_metadata: Julia Krämer Tanja Krömer-Olbrisch Heinz-Jürgen Lakomek Peter D Schellinger Dirk Foell Sven G Meuth Vera Straeten
article_metadata: 10.3389/fimmu.2020.02099
article_metadata: Front Immunol
article_metadata: 2020 Aug 28;11:2099.
article_metadata: adult onset still disease alemtuzumab anakinra case report multiple sclerosis rituximab secondary autoimmunity
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/33013884/
article_metadata: Alemtuzumab / administration & dosage Alemtuzumab / adverse effects Multiple Sclerosis / drug therapy Multiple Sclerosis / immunology Multiple Sclerosis / pathology Still's Disease, Adult-Onset / chemically induced Still's Disease, Adult-Onset / immunology Still's Disease, Adult-Onset / pathology
article_metadata: Alemtuzumab / administration & dosage Alemtuzumab / adverse effects Multiple Sclerosis / drug therapy Multiple Sclerosis / immunology Multiple Sclerosis / pathology Still's Disease, Adult-Onset / chemically induced Still's Disease, Adult-Onset / immunology Still's Disease, Adult-Onset / pathology Case Reports Adult Female Humans Alemtuzumab
article_metadata: PMC7493652
article_metadata: 33013884
article_metadata: Case Report: Adult Still's Disease in an Alemtuzumab-Treated Multiple Sclerosis Patient
article_metadata: 2020